AZTA
Azenta, Inc. NASDAQ Listed Feb 2, 1995$18.57
After hrs
$19.22
+0.00%
Mkt Cap $855.4M
52w Low $17.11
5.9% of range
52w High $41.73
50d MA $23.33
200d MA $30.20
P/E (TTM)
-20.4x
EV/EBITDA
21.2x
P/B
0.7x
Debt/Equity
0.1x
ROE
2.7%
P/FCF
34.3x
RSI (14)
—
ATR (14)
—
Beta
1.47
50d MA
$23.33
200d MA
$30.20
Avg Volume
961.6K
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
15 Elizabeth Drive · Burlington, MA 01824 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | BMO | 0.10 | -0.04 | -140.0% | 24.61 | — | — | -24.5% | — | — | — | — |
| Feb 4, 2026 | BMO | 0.11 | 0.09 | -18.2% | 28.49 | -1.8% | -2.2% | +0.8% | +4.6% | +5.3% | +6.9% | — |
| Nov 21, 2025 | BMO | 0.19 | 0.21 | +10.8% | 34.89 | +0.7% | +5.2% | +9.2% | +4.0% | +1.9% | -0.1% | — |
| Aug 5, 2025 | BMO | 0.13 | 0.19 | +46.2% | 26.90 | +4.0% | +5.6% | +8.3% | +7.9% | +4.0% | +8.6% | — |
| May 7, 2025 | BMO | 0.09 | 0.05 | -44.4% | 25.26 | +3.0% | +9.7% | +6.0% | +12.0% | +10.5% | +6.7% | — |
| Feb 5, 2025 | BMO | 0.05 | 0.08 | +60.0% | 53.76 | +1.2% | +0.5% | -2.7% | -11.6% | -14.7% | -15.7% | — |
| Nov 12, 2024 | BMO | 0.11 | 0.18 | +63.6% | 45.99 | +4.1% | -3.2% | -7.3% | -9.7% | -12.2% | -11.0% | — |
| Aug 6, 2024 | BMO | 0.07 | 0.16 | +128.6% | 58.34 | +3.9% | -8.9% | -4.2% | -5.3% | -6.8% | -6.9% | — |
| May 8, 2024 | BMO | 0.02 | 0.05 | +167.6% | 54.07 | -5.4% | -2.9% | -4.6% | -5.0% | -5.2% | -4.6% | — |
| Feb 7, 2024 | BMO | 0.01 | 0.02 | +159.7% | 65.05 | -1.6% | -1.6% | +0.1% | +1.4% | -1.9% | +0.9% | — |
| Nov 13, 2023 | BMO | 0.02 | 0.13 | +629.3% | 47.81 | +11.7% | +13.9% | +13.2% | +14.1% | +15.4% | +17.2% | — |
| Aug 8, 2023 | BMO | 0.02 | 0.13 | +713.8% | 48.00 | +15.9% | +20.3% | +16.0% | +17.0% | +16.8% | +18.7% | — |
| May 9, 2023 | AMC | -0.05 | -0.06 | -20.0% | 44.94 | -4.9% | -18.9% | -8.6% | -10.1% | -9.6% | -11.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $22.63 | $22.61 | -0.1% | -0.2% | -4.1% | -1.5% | +0.1% | -1.9% |
| Mar 17 | Needham | Maintains | Buy → Buy | — | $20.91 | $20.94 | +0.1% | +5.4% | +3.2% | -1.3% | -3.4% | -2.2% |
| Feb 5 | Evercore ISI | Maintains | Outperform → Outperform | — | $28.49 | $27.97 | -1.8% | -2.2% | +0.8% | +4.6% | +5.3% | +6.9% |
| Feb 4 | Jefferies | Maintains | Buy → Buy | — | $36.91 | $32.05 | -13.2% | -22.8% | -24.5% | -22.2% | -19.3% | -18.7% |
| Feb 4 | Needham | Maintains | Buy → Buy | — | $36.91 | $32.05 | -13.2% | -22.8% | -24.5% | -22.2% | -19.3% | -18.7% |
| Jan 8 | TD Cowen | Maintains | Hold → Hold | — | $37.51 | $37.21 | -0.8% | -0.0% | +1.1% | +0.1% | +2.6% | +5.3% |
| Jan 5 | Evercore ISI | Upgrade | In Line → Outperform | — | $33.39 | $34.25 | +2.6% | +7.1% | +10.8% | +12.3% | +12.3% | +13.6% |
| Dec 19 | Needham | Maintains | Buy → Buy | — | $34.50 | $34.43 | -0.2% | -0.2% | +0.6% | +0.6% | +0.0% | +0.7% |
| Nov 25 | Raymond James | Maintains | Outperform → Outperform | — | $36.70 | $36.93 | +0.6% | +3.8% | -1.2% | -3.1% | -5.0% | -4.2% |
| Nov 21 | Needham | Maintains | Buy → Buy | — | $30.00 | $34.00 | +13.3% | +16.3% | +22.3% | +27.0% | +20.9% | +18.5% |
| Oct 30 | Jefferies | Upgrade | Hold → Buy | — | $29.79 | $30.81 | +3.4% | +0.4% | +1.4% | +3.2% | +1.3% | +2.5% |
| Aug 6 | Raymond James | Upgrade | Market Perform → Outperform | — | $26.90 | $27.98 | +4.0% | +5.6% | +8.3% | +7.9% | +4.0% | +8.6% |
| Aug 5 | Evercore ISI | Maintains | In Line → In Line | — | $32.41 | $30.38 | -6.3% | -17.0% | -12.4% | -10.1% | -10.4% | -13.7% |
| Jul 8 | Evercore ISI | Maintains | In Line → In Line | — | $31.43 | $31.76 | +1.1% | +6.6% | +6.2% | +8.7% | +6.5% | +2.5% |
| May 7 | Needham | Maintains | Buy → Buy | — | $25.42 | $24.28 | -4.5% | -0.6% | +9.0% | +5.3% | +11.3% | +9.8% |
| Feb 6 | Needham | Maintains | Buy → Buy | — | $53.76 | $54.38 | +1.2% | +0.5% | -2.7% | -11.6% | -14.7% | -15.7% |
| Feb 6 | Evercore ISI | Maintains | In Line → In Line | — | $53.76 | $54.38 | +1.2% | +0.5% | -2.7% | -11.6% | -14.7% | -15.7% |
| Jan 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $50.00 | $50.43 | +0.9% | +0.1% | +1.0% | +3.8% | +3.8% | +3.6% |
| Dec 18 | Stephens & Co. | Upgrade | Equal Weight → Overweight | — | $46.31 | $47.48 | +2.5% | +7.2% | +6.9% | +8.9% | +8.0% | +8.5% |
| Nov 13 | Needham | Maintains | Buy → Buy | — | $45.99 | $47.86 | +4.1% | -3.2% | -7.3% | -9.7% | -12.2% | -11.0% |
| Oct 1 | Evercore ISI | Maintains | In Line → In Line | — | $48.44 | $48.07 | -0.8% | -1.9% | -1.5% | -2.1% | -0.4% | -2.4% |
| Aug 7 | Needham | Maintains | Buy → Buy | — | $58.34 | $60.60 | +3.9% | -8.9% | -4.2% | -5.3% | -6.8% | -6.9% |
| Jul 2 | Evercore ISI | Maintains | In Line → In Line | — | $51.04 | $51.29 | +0.5% | +1.0% | +1.8% | +2.4% | +2.8% | +1.3% |
| May 9 | Needham | Maintains | Buy → Buy | — | $54.07 | $51.15 | -5.4% | -2.9% | -4.6% | -5.0% | -5.2% | -4.6% |
| Apr 8 | Needham | Maintains | Buy → Buy | — | $57.48 | $57.62 | +0.2% | -1.3% | +0.6% | -2.0% | -1.9% | -4.7% |
| Apr 4 | Evercore ISI | Maintains | In Line → In Line | — | $59.01 | $59.38 | +0.6% | -1.4% | -2.6% | -3.9% | -2.0% | -4.5% |
| Mar 28 | Needham | Maintains | Buy → Buy | — | $59.43 | $59.71 | +0.5% | +1.4% | -0.7% | -1.0% | -0.7% | -2.1% |
| Mar 14 | Needham | Maintains | Buy → Buy | — | $64.11 | $64.11 | +0.0% | -7.6% | -7.2% | -9.2% | -8.4% | -8.5% |
| Mar 7 | Needham | Maintains | Buy → Buy | — | $64.91 | $65.00 | +0.1% | +3.4% | +0.7% | +0.4% | -0.3% | -1.2% |
| Feb 8 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $65.05 | $64.00 | -1.6% | -1.6% | +0.1% | +1.4% | -1.9% | +0.9% |
| Feb 8 | Needham | Maintains | Buy → Buy | — | $65.05 | $64.00 | -1.6% | -1.6% | +0.1% | +1.4% | -1.9% | +0.9% |
| Feb 1 | B. Riley Securities | Maintains | Buy → Buy | — | $65.20 | $65.63 | +0.7% | +1.4% | +1.4% | +0.7% | +2.3% | -0.2% |
| Jan 18 | Needham | Maintains | Buy → Buy | — | $64.56 | $64.73 | +0.3% | +2.4% | +4.4% | +4.2% | +3.1% | +0.9% |
| Nov 14 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $47.81 | $53.42 | +11.7% | +13.9% | +13.2% | +14.1% | +15.4% | +17.2% |
| Nov 14 | Needham | Maintains | Buy → Buy | — | $47.81 | $53.42 | +11.7% | +13.9% | +13.2% | +14.1% | +15.4% | +17.2% |
| Aug 9 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $48.00 | $55.62 | +15.9% | +20.3% | +16.0% | +17.0% | +16.8% | +18.7% |
| Aug 9 | Needham | Maintains | Buy → Buy | — | $48.00 | $55.62 | +15.9% | +20.3% | +16.0% | +17.0% | +16.8% | +18.7% |
| May 10 | Needham | Maintains | Buy → Buy | — | $44.94 | $42.72 | -4.9% | -18.9% | -8.6% | -10.1% | -9.6% | -11.5% |
| May 10 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $44.94 | $42.72 | -4.9% | -18.9% | -8.6% | -10.1% | -9.6% | -11.5% |
| Apr 18 | Needham | Maintains | Buy → Buy | — | $45.56 | $45.78 | +0.5% | -3.0% | -3.3% | -6.3% | -5.7% | -5.8% |
| Feb 10 | B. Riley Securities | Maintains | Buy → Buy | — | $45.94 | $45.66 | -0.6% | -2.5% | -1.9% | -1.0% | +1.9% | +1.0% |
| Feb 9 | Stephens & Co. | Downgrade | Overweight → Equal Weight | — | $56.22 | $51.50 | -8.4% | -18.3% | -20.3% | -19.8% | -19.1% | -16.8% |
| Feb 9 | Needham | Maintains | Buy → Buy | — | $56.22 | $51.50 | -8.4% | -18.3% | -20.3% | -19.8% | -19.1% | -16.8% |
| Jan 3 | Evercore ISI | Downgrade | Outperform → In Line | — | $58.22 | $57.41 | -1.4% | +1.2% | +3.5% | +3.3% | +5.1% | +4.1% |
| Nov 15 | Needham | Maintains | Buy → Buy | — | $46.58 | $62.09 | +33.3% | +21.8% | +25.6% | +27.9% | +23.6% | +22.3% |
| Oct 24 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $41.92 | $42.13 | +0.5% | +4.9% | +11.6% | +9.7% | +7.4% | +8.7% |
| Aug 10 | Needham | Maintains | Buy → Buy | — | $63.85 | $62.81 | -1.6% | -3.1% | -3.6% | -1.3% | +2.1% | -2.8% |
| May 17 | B. Riley Securities | Maintains | Buy → Buy | — | $74.57 | $75.99 | +1.9% | +1.7% | -5.1% | -5.8% | -6.6% | -5.1% |
| May 10 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $64.69 | $62.02 | -4.1% | +5.6% | +7.9% | +10.7% | +16.1% | +15.3% |
| May 10 | Needham | Maintains | Buy → Buy | — | $64.69 | $62.02 | -4.1% | +5.6% | +7.9% | +10.7% | +16.1% | +15.3% |
No insider trades available.
8-K · 2.02
!! High
Azenta, Inc. -- 8-K 2.02: Earnings Results
Azenta reported Q3 fiscal 2026 earnings on May 5, 2026, providing investors with updated financial performance metrics for the quarter ended March 31, 2026.
May 5
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
An experienced life sciences executive is joining one of these companies, likely signaling leadership transition or strategic expansion in biotech/pharma sectors, which could impact growth direction and investor confidence.
Apr 7
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
AZTA's proposed transaction faces financing risk and may not close as planned, creating uncertainty about the deal's completion that could significantly impact the stock price.
Apr 2
8-K · 1.01
!! High
Azenta, Inc. -- 8-K 1.01: Material Agreement
Azenta signed a material agreement with Antony Co., though specific terms remain undisclosed, potentially impacting the company's operations or financial position pending further details.
Mar 4
8-K
Azenta, Inc. -- 8-K Filing
Azenta reported its first quarter fiscal 2026 results for the period ended December 31, 2025, providing investors with updated financial performance metrics and operational insights.
Feb 4
8-K · 5.02
!!! Very High
Azenta, Inc. -- 8-K 5.02: Executive Change
Alan P. Malus's resignation as Azenta director effective January 29, 2026, represents a minor board composition change with limited immediate impact on the biopharmaceutical services company's operations or strategy.
Feb 2
Data updated apr 24, 2026 8:21pm
· Source: massive.com